Lehtileikkeet
- 1 - 25 osumaa 35 tuloksesta
Hakutulokset
-
University of Helsinki: Researchers Identified Factors That Turn Normal Cells Into Liver Cancer Cells
Sampsa Hautaniemi & Biswajyoti Sahu
08/09/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
388123-2021: Finland-Helsingin yliopisto: Services provided by medical laboratories
30/07/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
Tender Notice: HELSINGIN YLIOPISTO Seeks "Next Generation Sequencing Services for Decider" (118211-2021)
09/03/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
118211-2021: Finland-Helsinki: Services provided by medical laboratories
09/03/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
-
-KI researchers part of EU project to improve diagnostics and treatment of ovarian cancer with the help of AI
08/02/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
Researchers to create computational models to improve treatments for ovarian cancer
05/02/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
University of Helsinki: DECIDER Project to Improve Diagnostics and Treatment of Ovarian Cancer With the Help of AI - 15 Million Euros in Funding From the EU
05/02/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
European Union funds new project to improve personalized treatments for ovarian cancer
05/02/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
DECIDER project to improve diagnostics and treatment of ovarian cancer with the help of AI – 15 million euros in funding from the EU
04/02/2021
2 kohdetta/ Medianäkyvyys
Lehdistö/media
-
IndiTreat® selected to prestigious multinational ovarian cancer project.
04/02/2021
3 kohdetta/ Medianäkyvyys
Lehdistö/media
-
IRB Barcelona to participate in the DECIDER project, aimed at improving diagnostics and treatment of ovarian cancer
04/02/2021
1 kohde/ Medianäkyvyys
Lehdistö/media
-
Dana-Farber Cancer Institute: Scientists Identify Factors for Predicting Which Patients With Ovarian Cancer Won't Benefit From Immunotherapy-PARP Inhibitor Combination
20/03/2020
1 kohde/ Medianäkyvyys
Lehdistö/media
-
New research shows which ovarian cancer patients won't benefit from immune-PARP combo
19/03/2020
1 kohde/ Medianäkyvyys
Lehdistö/media
-
SCIENTISTS IDENTIFY FACTORS FOR PREDICTING WHICH PATIENTS WITH OVARIAN CANCER WON'T BENEFIT FROM IMMUNOTHERAPY-PARP INHIBITOR COMBINATION
19/03/2020
1 kohde/ Medianäkyvyys
Lehdistö/media
-
Dana-Farber Cancer Institute: Scientists identify factors for predicting which patients with ovarian cancer won't benefit from immunotherapy-PARP inhibitor combination
19/03/2020
1 kohde/ Medianäkyvyys
Lehdistö/media
-
Circulating tumor DNA gives treatment options for the most common ovarian cancer type
06/05/2019 → 08/05/2019
4 kohdetta/ Medianäkyvyys
Lehdistö/media
-
-
Circulating tumour DNA gives treatment options for the most common ovarian cancer type
07/05/2019
1 kohde/ Medianäkyvyys
Lehdistö/media
-
Liquid Biopsies Can Point to Best Ovarian Cancer Treatment
06/05/2019
1 kohde/ Medianäkyvyys
Lehdistö/media
-
Circulating tumor DNA can help detect treatment options for ovarian cancer subtype
06/05/2019
1 kohde/ Medianäkyvyys
Lehdistö/media
-
Circulating tumor DNA can help detect treatment options for ovarian cancer subtype
06/05/2019
1 kohde/ Medianäkyvyys
Lehdistö/media
-
-
-
Circulating tumor DNA gives treatment options for the most common ovarian cancer
04/05/2019
1 kohde/ Medianäkyvyys
Lehdistö/media